Targeted therapeutic delivery of vitamin D compounds |
| The present invention provides conjugates of vitamin D compounds or analogs and a targeting ... |
|
Production and use of monoclonal antibodies to phosphotyrosine-containing proteins |
| OF THE PREFERRED EMBODIMENTS A hybridoma secreting monoclonal antibodies that bind to PT-residues ... |
|
Trichothecene antibody conjugates |
| I claim: 1. A conjugate of a trichothecene and an antibody or antibody fragment, said antibody or ... |
|
Monoclonal antibody to human protein C |
| What is claimed is: 1. A monoclonal antibody which is specific to human protein C which has calcium ... |
|
Method for providing a cell culture from a transgenic non-human mammal |
| We claim: 1. A method of providing a cell culture comprising (1) providing a transgenic non-human ... |
|
Method of gene transfer into chickens and other avian species |
| A method is described for introducing foreign genes or foreign nucleic acid sequences into somatic ... |
|
DNA vector with isolated CDNA gene encoding metallopanstimulin |
| The present invention is based upon the discovery of a new and heretofore unrecognized type of ... |
|
Method for preparing immunoglobulin fragments |
| Pursuant to the present invention, there is provided an improved method for specific fragmentation ... |
|
Morpholino-subunit combinatorial library and method |
| The invention includes, in one aspect, a combinatorial library of non-biological oligomers formed ... |
|
Method of producing transgenic animals |
| What is claimed is: 1. A method for transferring DNA into fertilized eggs of a non-human mammal, ... |
|
|
Analogs of viscosin and their uses
| Details |
Inventors: Burke, Jr., Terrence; Chandrasekhar, Bhaskar; Knight, Martha;
Assignee: Peptide Technologies Corporation (Washington, DC)
Primary Examiner: Chan; Nicky
Assistant Examiner:
Attorney, Agent or Firm: Sterne, Kessler, Goldstein & Fox
This invention is directed to the analogs of viscosin, pharmaceutical compositions thereof and to their use as antibacterial, antiviral and antitrypanosomal therapeutic compounds. |
|
DETAILED DESCRIPTION OF THE INVENTION Viscosin is a peptide lactone composed of alternating D and L amino acids with a . beta. -D-hydroxydecanoyl dipeptide side chain. This peptide has antibacterial, antiviral and antitrypanosomal activity against Tyrpanosoma cruzi, the pathogen involved in the South American Chagas' disease. The synthesis by solid phase methods utilizing an acid sensitive resin and a combination of Fmoc/Boc amino protection is described in Example 1. In an effort to develop antichagasic agents based on viscosin, a series of analogs were prepared which were synthetically more accessible. One aspect of this invention involves alteration of the peptide side chain and ring junction. Side chain analogs consist of a variety of linear alkyl amides while modifications in the ring junction involve replacing the D-allo-Thr with D-Thr. Synthesis of these analogs is based on those techniques used to prepare viscosin itself, and rely on the novel use of activated esters of pentafluorophenol for the coupling of unprotected hydroxyl-bearing amino acids. A second aspect of this invention addresses the rate of ion transport in viscosin's anticruzi activity and involves replacement of the peptide lactone ring with a crown ether. In general, any crown ether that has ionophore properties may be substituted for the peptide lactone ring of viscosin. Preferable crown ethers include benzo-15-crown-5 polyether, dibenzo-18-crown-6 polyether, dibenzo-24-crown-8 polyether, 2-hydroxymethyl-12-crown-4, 2-hydroxymethyl-15-crown-5 polyether, and 2-hydroxymethyl-18-crown-6 polyether. A most preferable crown ether is benzo-15-crown-5 polyether. These analogs may further differ from each other in the side chain R which are long chain alkylamides or simple peptides. The viscosin analogs comprising crown ethers may be prepared according to the general methods of synthesis set forth in the examples section of the application. For example, where the crown ether is fused to a benzene ring, it is possible to nitrate the ring with nitric acid, followed by reduction to give the amine followed by the condensation thereof with an appropriate side chain precursor to give the viscosin derivative
|
| Related patents |
|
|
Single polypeptide chain binding molecules
The present invention starts with a computer based system and method to determine chemical structures for converting two naturally aggregated but chemically separated ...
|
|
|
Bcl-2 and R-ras complex
Generally, the nomenclature used hereafter and the laboratory procedures in cell culture, molecular genetics, and nucleic acid chemistry and hybridization described ...
|
|
|
Heterodimeric receptor libraries using phagemids
A new surface-integration technology has been discovered for expressing a heterodimeric recombinant gene product on the surface of a filamentous phage containing the ...
|
|
|
Method for producing highly reactive polyisobutenes
We claim: 1. A process for the preparation of highly reactive polyisobutenes, in which a) isobutene is polymerized in the presence of a complex of boron trifluoride and ...
|
|
|
Device and mixture for testing for immune responses to food
In accordance with the present invention the aforementioned needs are fulfilled by providing an inexpensive, simple and quick test for detecting an individual's Type I, I...
|
|
|
Compounds for immunotherapy of prostate cancer and methods for their use
OF THE INVENTION As noted above, the present invention is generally directed to compositions and methods for the immunotherapy of prostate cancer. The inventive ...
|
|
|
Compositions and methods for the therapy and diagnosis of prostate cancer
Briefly stated, the present invention provides compositions and methods for the diagnosis and therapy of cancer, such as prostate cancer. In one aspect, the present ...
|
|
|
Superantigen based methods and compositions for treatment of diseases
What is claimed is: 1. A pharmaceutical compound comprising a therapeutic antigen and superantigen, wherein said super antigen is conjugated to the therapeutic antigen ...
|
|
|
Tetra and penta-peptides useful in regulating the immune system
The present invention describes a series of thysplenin peptide analogs capable of regulating the function of cells of the immune system. As one aspect, the present ...
|
|
|
Peptide fragments of myelin basic protein
OF THE INVENTION All patent applications, patents and publications cited in this specification are hereby incorporated by reference in their entirety. In the case of ...
|
|
|